Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Administration of Low Molecular Weight Heparin and Aspirin Versus Aspirin Alone in Gravidas at High Risk for Preeclampsia: A Randomized Controlled Trial

NCT07361679 is registered in ClinicalTrials.gov with Alexandra Hospital, Athens, Greece as lead sponsor.

NCT NCT07361679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07361679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Administration of Low Molecular Weight Heparin and Aspirin Versus Aspirin Alone in Gravidas at High Risk for Preeclampsia: A Randomized Controlled Trial
Lead sponsor
Alexandra Hospital, Athens, Greece
Phase
Phase 4
Overall status
Recruiting
Start date
January 18, 2023
Completion date
July 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational hypertension, hypertension, pregnancy-induced, preeclampsia, preeclampsia severe, pregnancy complications, toxemia of pregnancy